Memphasys: A rare medical device that made it to all the way to commercialisation – and in a huge market! Memphasys Managing Director Dr...

This just might be a medical revolution – no more agonising waits for pathology results!

From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

An oral cancer drug trial with serious results!

No more biopsies? – a serious revolution in medical science

Medical software for military veterans – now that sounds scalable!

A worldwide license to attack blood cancer

So this is different; a med-tech product with actual sales!

Singular Health Group: A sci-fi collaboration with a global electronics juggernaut Singular Health Managing Director Tom Hanly on 6PR...